Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and
客服專線︰ +852 3018 4526
交易日︰全日24小時 | 非交易日：9:00-18:00
